BlackRock Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $192K | Buy |
3,619
+145
| +4% | +$7.69K | ﹤0.01% | 2668 |
|
|
2016
Q3 | $211K | Buy |
3,474
+379
| +12% | +$23K | ﹤0.01% | 2598 |
|
|
2016
Q2 | $204K | Sell |
3,095
-4,021
| -57% | -$265K | ﹤0.01% | 2551 |
|
|
2016
Q1 | $404K | Sell |
7,116
-2,440
| -26% | -$139K | ﹤0.01% | 2157 |
|
|
2015
Q4 | $2.25M | Sell |
9,556
-2,131
| -18% | -$501K | ﹤0.01% | 1342 |
|
|
2015
Q3 | $1.85M | Sell |
11,687
-10,889
| -48% | -$1.72M | ﹤0.01% | 1373 |
|
|
2015
Q2 | $8.54M | Sell |
22,576
-5,510
| -20% | -$2.08M | 0.01% | 794 |
|
|
2015
Q1 | $11.7M | Buy |
28,086
+2,811
| +11% | +$1.18M | 0.01% | 720 |
|
|
2014
Q4 | $6.92M | Buy |
25,275
+672
| +3% | +$184K | 0.01% | 867 |
|
|
2014
Q3 | $4.78M | Sell |
24,603
-2,631
| -10% | -$511K | ﹤0.01% | 962 |
|
|
2014
Q2 | $6.67M | Buy |
27,234
+19,980
| +275% | +$4.89M | 0.01% | 877 |
|
|
2014
Q1 | $1.92M | Buy |
7,254
+3,428
| +90% | +$909K | ﹤0.01% | 1174 |
|
|
2013
Q4 | $1.39M | Sell |
3,826
-76,800
| -95% | -$27.9M | ﹤0.01% | 1302 |
|
|
2013
Q3 | $42.8M | Sell |
80,626
-41,300
| -34% | -$21.9M | 0.04% | 349 |
|
|
2013
Q2 | $28.5M | Buy |
+121,926
| New | +$28.5M | 0.03% | 428 |
|